1,2 Juta Dosis Vaksin Sinovac Telah Tiba di Indonesia

Indonesia receives over a million Chinese Covid-19 vaccine doses

Editor : Ismail Gani
Translator : Novita Cahyadi


1,2 Juta Dosis Vaksin Sinovac Telah Tiba di Indonesia
Vaksin Sinovac tiba di Jakarta pada Minggu Malam [6/12] dalam penerbangan dari Beijing. [Foto: AFP/MailOnline]

SEBANYAK 1,2 juta dosis vaksin Covid-19 buatan biofarmasi asal Cina, Sinovac, telah tiba di Indonesia.

Vaksin Sinovac tiba di Jakarta pada Minggu malam [6/12] dalam penerbangan dari Beijing langsung disambut baik oleh Presiden Joko Widodo, serta diharapkan 1,8 juta dosis lagi dapat dikirim bulan depan.

"Saya ingin menyampaikan suatu kabar baik, bahwa hari ini pemerintah sudah menerima 1,2 juta dosis vaksin Covid-19," kata Presiden Joko Widodo 

"[Tapi] saya harus tegaskan, pertama, semua prosedur harus diikuti dengan benar untuk memastikan kesehatan dan keselamatan masyarakat, dan keberhasilan vaksin," tambahnya.

Pada Agustus, Indonesia telah bekerja sama dengan Sinovan untuk meluncurkan lab uji coba, dengan 1.6000 sukarelawan yang diambil untuk keperluan riset selama enam bulan tersebut.

Pemerintah Indonesia telah membayar sekitar Rp 637 miliar untuk tiga juta dosis Sinovac. 100.000 lagi akan dikirimkan oleh perusahaan Cina lainnya, CanSino.

"Kami berharap vaksin multilateral [dari negara lain] juga ikut tiba secara bertahap pada 2021," kata Menteri Luar Negeri, Retno Marsudi pada Senin.

Indonesia juga telah berkomunikasi dengan perusahaan farmasi lainnya, termasuk AstraZeneca asal Inggris seperti dikutip AFP yang dilansir MailOnline.

INDONESIA has received 1.2 million doses of a Covid-19 vaccine made by China´s Sinovac.

The vaccine arrived in Jakarta late Sunday on a flight from Beijing and was immediately welcomed by President Joko Widodo, with another 1.8 million expected to be sent again next month.

"I want to convey the good news, that today the government has received 1.2 million doses of vaccine Covid-19," said President Joko Widodo

"(But) I have to reiterate, first, that all procedures must be followed properly to ensure public health and safety, and the efficacy of the vaccine," he added.

In August, Indonesia launched human trials of the Sinovac-made jab, with around 1,600 volunteers taking part in the six-month study.

The Indonesian government has paid some 637 billion rupiah ($45 million) for the three million Sinovac doses. Another 100,000 more are set to be delivered by another Chinese firm, CanSino.

"We expect that multilateral vaccines [from other countries] will also start to arrive gradually in 2021," Foreign Minister Retno Marsudi said Monday.

Indonesia has been in talks with other pharmaceutical firms, including UK-based AstraZeneca.